logo-loader
Minds + Machines Group Limited

Minds + Machines set to launch adult domain name trademark protection service

The new service will allow trademark holders to affordably block both exact match terms across all four of MMX's adult TLDs as well as the many look-alike variations

adult xxx
The new service will be rolled out next month

Minds + Machines Group Limited (LON:MMX) has announced that domain name regulator ICANN is to introduce a new blocking service that will allow trademark holders to better protect their naming rights across the .xxx, .sex, .porn and .adult four top level domains (TLDs).

MMX acquired the four adult-themed domains last year through its acquisition of ICM Registry.

READ: MMX rakes in US$100k from first sale of .luxe domains

The new service is set to be formally unveiled to the corporate registrar channel on 15 July.

It will allow trademark holders to affordably block both exact match terms across all four of MMX's adult TLDs as well as the many look-alike variations that can be easily generated by bad actors to spoof users to visit websites containing malicious code used in phishing and malware scams

MMX's technical and marketing partner on the initiative will be Uniregistry, a recognised leader in providing name blocking technology.

“We are truly delighted to have received approval from ICANN and to be working with Uniregistry on the introduction of our new service to the corporate registrar channel,” said chief executive Toby Hall.

“The Uniregistry team have the right balance of technical expertise and corporate registrar reach to be our ideal partner.

“We very much look forward to unveiling the full details of our new adult blocking service, that will initially be targeted at trademark holders and participants in the original .xxx Sunrise B* launch, next month.”

MMX shares rose 2.6% to 5.9p on Thursday morning.

Quick facts: Minds + Machines Group Limited

Price: £0.06

Market: AIM
Market Cap: £53.12 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Minds + Machines Group Limited named herein, including the promotion by the Company of Minds + Machines Group Limited in any Content on the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Shield Therapeutics targets $1bn US market after FDA...

Top stories from the Proactive Investors UK newsroom. Shield Therapeutics (LON:STX) has been given approval by the US Food and Drug Administration to sell its lead product Feraccru as a treatment for iron deficiency in adults. The US prescription market for iron replacement therapy is...

on 26/7/19

2 min read